Abstract
Eosinophilic esophagitis (EoE) is one of the most prevalent esophageal diseases and the leading cause of dysphagia and food impaction in children and young adults.
Eosinophilic esophagitis (EoE) is a chronic immune/antigen-mediated disease of the esophagus, clinically characterised by symptoms of esophageal dysfunction and histologically by severe eosinophilic inflammation. Currently, the only reliable method for diagnosing EoE is endoscopy with biopsy. The minimum threshold criterion for the diagnosis of EoE is 15 eosinophils in the field of view at high magnification (standard size ≈0.3 mm2) in the esophageal mucosa. If EoE is suspected, the allergic status should be assessed.
First-line therapy for EoE includes an elimination diet, proton pump inhibitors, and topical corticosteroids.
EoE has a relatively favourable course (provided timely diagnosis and treatment), as this pathology is not a precancerous condition.
Macroamylasemia should be suspected when blood amylase activity is elevated but urine amylase levels are normal and there are no signs of pancreatic or salivary gland pathology. A simple and affordable method of diagnosing macroamilasemia is determining the ratio of amylase and creatinine clearances.
Macroamilasemia cannot be treated, but only monitored. If necessary, the disease that may have caused the formation of macroamilasemia is treated.
A clinical case of a patient with EoE and macroamylasemia is presented. The ACG’s еvidence-based recommendations for EoE diagnosis, treatment modalities, and patients’ follow up are shown in the article. The article represents definition and forms of macroamylasemia, clinical significance and prognosis.
References
2. Губергриц Н. Б., Лукашевич Г. М., Загоренко Ю. А. Макроамилаземия — безобидное заблуждение или опасное незнание? Сучасна гастроентерологія. 2006; 6(32): 93–99.
3. Ивашкин В. Т., Баранская Е. К., Трухманов А. С., Кайбышева В. О. Эозинофильный эзофагит. Учебное пособие для врачей. Москва. 2013:78.
4. Collins M. H., Capocelli K., Yang G.-Y. Eosinophilic Gastrointestinal Disorders Pathology. Front. Med. 2018; 4: 261. https://doi.org/10.3389/fmed.2017.00261
5. Dellon E. S., Muir A. B., Katzka D. A. et al. ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis. Am J Gastroenterol. 2025; 120(1): 31–59. https://doi.org/10.14309/ajg.0000000000003194.
6. Diny N. L., Rose N. R., Ciháková D. Eosinophils in Autoimmune Diseases. Front Immunol. 2017; 8: 484. https://doi.org/10.3389/fimmu.2017.00484.
7. Durrani S., Rothenberg M. Recent advances in eosinophilic esophagitis [version 1; referees: 3 approved]. F1000Research 2017; 6(F1000 Faculty Rev): 1775. https://doi.org/10.12688/f1000research.11798.1.
8. Lucendo А., Molina-Infante J., Arias А. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017; 5(3): 335–358. https://doi.org/10.1177/2050640616689525.
9. Ronkainen J., Talley N. J, Aro P. et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007; 56(5): 615–620.
10. Schooepfer A. M., Safroneeva E., Bussmann C. et al. Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner. Gastroenterology. 2013; 145: 1230–1236.